Related Experiment Video
Updated: May 21, 2026
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Synthesis, characterization, cell imaging and anti-tumor activity of multifunctional nanoparticles
Qiu-Yun Chen1, Gen-Ping Tao, Ying-Qi Liu
1School of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang 212013, PR China. chenqy@ujs.edu.cn
Abstract:
Most anticancer complexes are unable to differentiate between diseased and healthy cells, systemic toxicity and undesired side effects can result. In the current study, a PEG and RGD peptides functionalized fluorescent dye Rhodamine B isothiocyanate (RBITC) doped magnetic silica nanoparticle (MnFe(3)O(4)@SiO(2)-PEG-RGD), carrying a anticancer superparamagnetic Mn(II) complex, was synthesized and characterized using spectroscopic methods. The multifunctional nanoparticles (MnFe(3)O(4)@SiO(2)-PEG-RGD) can image HepG-2 cells and differentiate between HepG-2 and WRL-68 cells based on T(1) MR imaging technology. The in vitro fluorescence image and inhibition assay on the proliferation of HeLa cells indicate that MnFe(3)O(4)@SiO(2)-PEG-RGD nanoparticles can effectively reach the tumor site, be internalized by endocytosis and then retain in cancer cells due to the retention effect of nanoparticles. This study demonstrated that a PEG and RGD peptides functionalized silica nanoparticle was a good carrier for the anticancer complexes, and the anticancer complexes loaded multifunctional nanoparticles could be developed as special agents in monitoring therapy of cancer.
Insights
This study developed novel magnetic silica nanoparticles carrying anticancer complexes. These targeted nanoparticles can image cancer cells and monitor treatment effectiveness, reducing side effects.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Conventional anticancer drugs often lack specificity, leading to systemic toxicity and side effects.
- Targeted drug delivery systems are crucial for improving cancer treatment efficacy and patient outcomes.
Purpose of the Study:
- To synthesize and characterize a multifunctional nanoparticle for targeted cancer therapy and imaging.
- To evaluate the nanoparticle's ability to differentiate between cancer and healthy cells.
- To assess the nanoparticle's efficacy in delivering anticancer complexes and monitoring treatment.
Main Methods:
- Synthesis and spectroscopic characterization of PEG and RGD peptide functionalized magnetic silica nanoparticles (MnFe(3)O(4)@SiO(2)-PEG-RGD) loaded with an anticancer Mn(II) complex.
- T(1) Magnetic Resonance (MR) imaging to differentiate between HepG-2 and WRL-68 cells.
- In vitro fluorescence imaging and cell proliferation inhibition assays on HeLa cells.
Main Results:
- The synthesized MnFe(3)O(4)@SiO(2)-PEG-RGD nanoparticles demonstrated successful imaging of HepG-2 cells.
- The nanoparticles effectively differentiated between HepG-2 and WRL-68 cells using T(1) MR imaging.
- In vitro studies confirmed nanoparticle internalization by endocytosis and retention in cancer cells, with significant inhibition of HeLa cell proliferation.
Conclusions:
- PEG and RGD peptide functionalized silica nanoparticles serve as effective carriers for anticancer complexes.
- These multifunctional nanoparticles show potential as theranostic agents for monitoring cancer therapy.
- The developed system offers a promising approach for targeted cancer treatment with reduced systemic toxicity.
